{
    "nct_id": "NCT06662435",
    "official_title": "A Pilot and Mixed-Methods Study of GYNecologic Cancer-Related COGnitive Impairment",
    "inclusion_criteria": "* Female; â‰¥18 years of age\n* Presents to clinic with a confirmed diagnosis of a gynecologic cancer (e.g., ovarian, endometrial, cervical, or vulvar cancer) who have completed adjuvant chemotherapy with at least stable disease at time of screening.\n* Screen positive for subjective cognitive impairment by answering affirmatively to at least one of three screener questions\n* Fluent in spoken and written English\n* Have access to the internet to complete assessments\nHealthy volunteers allowed\nMust be FEMALE\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Patients who have not received chemotherapy\n* Patients with pre-existing neuropsychiatric disorders that would impact cognitive function, such as dementia, Alzheimer's disease, and schizophrenia.\n* Patients with non-gynecologic causes of incurable metastatic cancers.\n* Patients undergoing active interventions in other cognitive trials or patients currently using cognitive training programs such as Brain HQ, Luminosity, Elevate, Peak, Fit Brains, or CogniFit.\n* Patients with self-report of learning disability or an unwillingness to participate in technology-based cognitive training programs.\n* Pregnant women or prisoners\n* Patients with impaired-decision making capacity",
    "miscellaneous_criteria": ""
}